5/14/2026China Launches Sweeping Crackdown on Pharmaceutical Kickbacks and Sale...

5/14/2026Metis Shares Surge in Hong Kong IPO Debut After Raising $270M

5/14/2026Life Sciences a "Sweet Spot" for U.S.-China Cooperation Ahead of Trump...

5/14/2026Pharma CEOs Missing From Trump's China Delegation

5/13/2026Strategic Partnerships Redefine China's Biotech Innovation Model: CBPF

5/12/2026BMS Strikes Up to $15.2B Hengrui Alliance to Accelerate Global Drug De...

5/12/2026China Holds National Healthcare Reform Meeting, Prioritizes Public Hos...

5/12/2026China Moves to Expand Maternity Insurance Coverage and Birth-Related B...

5/12/2026BrightGene Reports Phase 3 Success for Dual GLP-1/GIP Obesity Drug BGM...

5/11/2026NHC Seeks Comments on Revised Human Genetic Resources Regulation Imple...

5/11/2026CDE Releases Draft MSC Stem Cell Product Guideline for Public Consulta...

5/8/2026Viatris Tops Quarterly Estimates on Strong China Performance and Brand...

5/8/2026China Unveils Tougher Nationwide Rules Governing Medical Representativ...

5/8/2026Recent Executive Moves

5/7/2026Amgen Wins China Approval for Evenity (Romosozumab)

5/7/2026Novo Nordisk Signals Delays for Ozempic Generics in China Despite Pate...

5/7/2026Sino Biopharm Wins China Approval for World's First CDK2/4/6 Inhibitor...

5/6/2026NHSA Solicits Comments on National Body Part Coding System to Strength...

5/5/2026UCB's $2.2B Candid Deal Highlights China-Origin Innovation Flowing Int...

5/5/2026Bambusa Completes Enrollment in Mid-Stage Trial of Bispecific Antibody...

5/5/2026China Tightens Biopharma Supply Chain Controls, Raising Stakes for MNC...

5/5/2026Gyre Thera Closes $300M Cullgen Deal

5/5/2026A Strategic Playbook for Chinese Biotech Cross-Border Deals: Navigatin...

5/1/2026A Biopharmaceutical Superpower: China's Rise, Its Limits, and What Com...

5/1/2026China Pharma Trade Rises 4.22% in Q1 as Exports Shift Toward High-Valu...

5/1/2026China Approves Two Innovative Homegrown Therapies Ahead of Holiday Bre...

5/1/2026EU Approves Henlius–Organon Pertuzumab Biosimilar POHERDY

5/1/2026Shanghai Pharma Completes Exit from Sino-US JV with $140M Stake Sale t...

5/1/2026Recent Official and Executive Moves

4/30/2026Livzon Takes Control of Vietnam's Imexpharm in $228M Deal

Page:1/387 Total number of articles:11583: [First][<<] [1] [2] [3] [4] [5] [>>] [End]